Author name: Swaraj Paul Barooah

.

SpicyIP Event: IPEX – 2013, Hyderabad

/ By / Uncategorized

As mentioned last week, SpicyIP is happy to announce IPEX – 2013, a conference and exposition on “Building and Managing an IP Ecosystem for Business Excellence”. This promises to be an excellent event and we hope that all interested parties are able to attend it. The event is partnered by the Indian Patent Office, USPTO-GIPA as well as Nalsar University of Law. We’re also happy to announce that SpicyIP is the Media partner for this event. Please see the details […]

SpicyIP Event: IPEX – 2013, Hyderabad Read More »

SpicyIP Event: IPEX – 2013, Hyderabad

/ By / Uncategorized

SpicyIP is happy to announce IPEX – 2013, a conference and exposition on “Building and Managing an IP Ecosystem for Business Excellence”. The event is partnered by the Indian Patent Office, USPTO-GIPA as well as Nalsar University of Law. We’re also happy to announce that SpicyIP is the Media partner for this event. Please see the details as below. SpicyIP readers should note that mentioning SpicyIP at the time of registration will give them a 30% discount on registration fees

SpicyIP Event: IPEX – 2013, Hyderabad Read More »

Battleground shopping: Big Pharma versus Indian Patent policy

/ By / Patent

On March 13th 2013, in a hearing before the US House of Representatives, Pfizer’s Chief Intellectual Property Counsel Roy Waldron derided India’s pharmaceutical patent regime stating amongst other things that India has ‘routinely flouted trade rules’, discriminating in favour of domestic generic companies, and is abusing the compulsory license system. Waldron went on to recommend that the US government use ‘every available bilateral and multilateral fora’ and ‘review all available policy tools’ in order to send strong signals to the

Battleground shopping: Big Pharma versus Indian Patent policy Read More »

WIPS (Worldwide Intellectual Property Service) – IPR Solution experts

/ By / Uncategorized

SpicyIP is happy to bring to our readers news of a wonderful set of search and analytics tool by Worldwide Intellectual Property Service (WIPS) for those involved in the IP field. Please see as below: WIPS (Worldwide Intellectual Property Service) – IP Solution experts Description: WIPS, as a leader in the intellectual property fields, is endeavoring to provide various solutions for which clients may have difficulty in IP related issues. WIPS is Korea’s first company to offer online worldwide patent

WIPS (Worldwide Intellectual Property Service) – IPR Solution experts Read More »

Guest post: Avoiding Open Source Surprises When Buying Proprietary Software

/ By / Uncategorized

We’re happy to bring to our readers a brief note by Protecode on protecting against the risks of Open Source Software being incorporated in purchased proprietary software without the knowledge of the buyer.  A bit about the authors: Mahshad Koohgoli, CEO of Protecode, has more than 25 years of experience in the technology industry. Previously, he was founder and CEO of Nimcat Networks (acquired by Avaya in 2005) and founder of Spacebridge Networks and Lantern Communications Canada. Mahshad has a BSc

Guest post: Avoiding Open Source Surprises When Buying Proprietary Software Read More »

Social Innovations: A Braille Smartphone

/ By / Others

Even as the draft Treaty for the Blind gets watered down and seems to be heading towards a failure (due to “competing” corporate copyright interests), an Indian company Kriyate Design Solutions seems  to be on the road to making more ‘every day’ things accessible to print impaired people by introducing the world’s first Braille smartphone! The difficulties faced by the print impaired is a topic we have often visited on this blog and it’s with pleasure we bring you some good news

Social Innovations: A Braille Smartphone Read More »

USTR’s Special 301 Process 2013 – India on Priority Watchlist

/ By / Uncategorized

Image from here A few years ago, a study done on a certain “of the people, by the people and for the people” governed country revealed that 62% of all its personal bankruptcy filings were due to medical bills. I’m not sure if their situation has since improved (though I hope it has) but it is with some ironic amusement that I read America’s latest USTR Special 301 Report advising India on how ‘to promote access to healthcare products’. [pg 24].

USTR’s Special 301 Process 2013 – India on Priority Watchlist Read More »

Guest Post: US Supreme Court hears oral arguments for Gene Patents case

/ By / Patent

Image from here We’re happy to bring you a guest post by Samantak Ghosh on the recent AMP v. Myriad Gene Patents case argued before the US Supreme Court on April 15th, 2013. Please see our previous post here for a detailed explanation on the background of the case. Samantak (JD Candidate ’13, Berkeley Law) also recently won the American Intellectual Property Law Association’s national student writing award for his paper on the policy ramifications of the Supreme Court’s recent decision

Guest Post: US Supreme Court hears oral arguments for Gene Patents case Read More »

Life of P.I. – Keynote address by Justice Prabha Sridevan

/ By / Patent, Trademark

Justice Prabha Sridevan, Chairman of the IPAB, who just a few days ago upheld India’s first post TRIPs era Compulsory License, gave a very well received speech “Life of P.I.” (Public Interest) as the keynote speaker for the MIP India and Innovation Forum held in Delhi yesterday. Her marathon 7 hour dictation while upholding the compulsory license order started out by establishing that ‘Compulsory Licensing’ is not a bad word and her keynote address yesterday seemed to place that thought in

Life of P.I. – Keynote address by Justice Prabha Sridevan Read More »

SpicyIP Event: Announcing Expert Speaker Panel for Pharma IPR 2013

/ By / Uncategorized

We’d like to remind our readers of the 2nd Annual Pharma IPR 2013 conference taking place from 10th – 12th April, 2013 in Mumbai, India. This exclusive conference is specifically designed for intellectual property professionals from the pharma and biopharma industry to gain an in-depth understanding about evolving global IPR practices, updates on the patent regime and strategies to enter new and emerging markets. Patent regimes and market entry strategies will be discussed of over 10 countries including: USA, Europe,

SpicyIP Event: Announcing Expert Speaker Panel for Pharma IPR 2013 Read More »

Scroll to Top